Lessons From Hollywood: A New Approach To Funding R&D
Companies find it challenging to justify long-term, risky R&D investments — particularly in science-based fields such as biotechnology. Maybe it’s time to consider a different financing model.
Science-based industries such as biotechnology offer the potential of high growth, but they are fraught with risk. The payoffs, if they ever come, can take many years to materialize. Amid intensifying capital market pressures for short-term financial results, even large and successful companies are finding it increasingly challenging to justify longer-term risky research and development investments. The challenge is particularly acute in research-intensive ...
Get Lessons From Hollywood: A New Approach To Funding R&D now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
